Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

MK 0677

Known as: MK 677, MK-0677, MK-677 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Some growth hormone secretagogues act as agonists at the ghrelin receptor and have been described as "ago-allosteric" ligands… Expand
Is this relevant?
Highly Cited
2005
Highly Cited
2005
Two nonpeptide (L692,429 and MK-677) and two peptide [GH-releasing peptide (GHRP)-6 and ghrelin] agonists were compared in… Expand
Is this relevant?
2004
2004
OBJECTIVES To evaluate the effects of MK-0677, an orally active growth hormone (GH) secretagogue, on functional recovery from hip… Expand
Is this relevant?
1999
1999
It has been well established that the spiroindoline sulfonamide MK-0677 stimulates GH secretion from the pituitary both in vitro… Expand
Is this relevant?
1998
1998
The effect of 2 months of treatment with the oral growth hormone (GH) secretagogue MK-677 on markers of bone metabolism was… Expand
Is this relevant?
1998
1998
There is accumulating evidence that the hypothalamic arcuate nucleus plays an important role in mediating the effects of growth… Expand
Is this relevant?
Highly Cited
1998
Highly Cited
1998
Obesity is associated with blunted GH secretion, unfavorable body composition, and increased cardiovascular mortality. The… Expand
Is this relevant?
1998
1998
The reversal of diet-induced negative nitrogen balance by GH suggests a possible therapeutic role for GH treatment in catabolic… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
1997
1997
We have reported that MK-0677 is a novel, orally active GH secretagogue that stimulates an immediate and long-lasting increase in… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
1996
1996
MK-0677, a spiroindoline sulfonamide, is a novel, orally active GH secretagogue. The effects of MK-0677 on serum GH and other… Expand
Is this relevant?